EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesEuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicineRevisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemiaDiagnosis and subclassification of acute lymphoblastic leukemiaMinimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesPrognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemiaMolecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disordersStandardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping ConsortiumMeasurable residual disease testing in acute myeloid leukaemia.Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study.Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.Methods for discovery and characterization of cell subsets in high dimensional mass cytometry dataDevelopment-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical ResearchValidation of an automated technique for ovarian cortex dissociation: isolation of viable ovarian cells and their qualification by multicolor flow cytometryRecent advancements of flow cytometry: new applications in hematology and oncology.Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing.Sera from patients with active systemic lupus erythematosus patients enhance the toll-like receptor 4 response in monocyte subsets.Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemiaMSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometryAnalysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood.Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females.Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemiaAssociation of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemiaAltered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.Measurement of the T Cell Response to Preerythrocytic Vaccination in Mice.Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia.Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.Is minimal residual disease monitoring clinically relevant in adults with acute myelogenous leukemia?Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.Immune monitoring in cancer vaccine clinical trials: critical issues of functional flow cytometry-based assays.DNA-directed assembly of antibody-fluorophore conjugates for quantitative multiparametric flow cytometry.Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.Minimal Residual Disease Monitoring in Adult ALL to Determine Therapy.Implementation of highly sophisticated flow cytometry assays in multicenter clinical studies: considerations and guidance.
P2860
Q24604581-D815993C-A6E8-437D-9C21-59CF65E53B94Q24605023-9BB66833-6789-4E63-9E7C-35FB62C13C1BQ26783577-65A5D842-D1C9-4460-9BA5-FFDE52B91E25Q26824387-F10FC471-D102-49E7-813F-7B32E2B8AB81Q26828511-D722F268-64DA-4C60-8126-B01B94D639D9Q27006773-B601AFAC-2AEB-4A0C-B392-6F494D80313FQ28385156-BEE367C3-13B9-44D6-B9DF-6231DB92B51CQ28601097-F9332B00-D137-4DE0-ADAE-B85B328C52AEQ30234914-6474AEF8-E184-4FA5-85F0-5EE6BDF26808Q30682927-E728414D-FCE9-48BE-8012-5A5F682B52FBQ30938779-C620B98E-CFE9-4C12-8F87-F98F4ABB0435Q30952528-1187F4AF-4422-4579-8893-3657262328E2Q33590468-0D26E6AE-0375-44A1-9B80-D70A5F952226Q33756582-CF4C14BF-F9D3-4D5D-BAC6-4EAD782AB53AQ33827472-3E3641C3-4012-4D18-864B-F0F5537BFFCAQ35059549-2EB23986-4A87-4CF9-A384-AEDE3A2B8544Q35146272-A0FCA486-59F0-412E-93C5-82397040069AQ35178180-F3101622-3267-4528-B957-5517E4A3DFB7Q35672923-AB2318D9-EDE7-4230-9624-668729B08FD0Q35691393-CA8AC0C8-C915-4D33-A293-3BDF75216319Q36088901-6FDBC7C2-5617-42C7-BF54-8A3A5E0151B8Q36371093-142083FF-999D-40A8-940F-8C2B10B5AB4EQ36454220-70284BD2-870B-48B6-826A-50282EBF0806Q36498366-36801285-12FB-43C7-9A23-B51DAF98092CQ36660666-A51825F6-32D5-4D9A-81A1-9DF37E92E670Q36950617-DC4F69ED-9B1B-451A-B0AC-D1B035D2C416Q36981193-4174B055-D315-4352-971B-6B5544EBEC45Q37101299-786B2B5F-DB97-410C-A500-66DD957EE79AQ37148110-2512995C-B769-48B8-97DE-E4954A8A77C8Q37269402-FDF75311-71EB-4C66-B567-4C1A09A80FEEQ37385314-A2E41907-A187-4FEA-9C0F-649F48BE4309Q37624584-BA581D7C-C580-4933-B185-DD9D63F04198Q37673367-BCACF7D2-44CB-400D-9C6B-222748E717BDQ38096909-D182474C-29BC-48B2-8CA2-1211F6AC0072Q38123692-9A0194E2-FAFB-4AE2-BCF1-F7645CF125D4Q38160232-06FDE144-FC65-4CE7-BA71-C722E3124290Q38310103-4AD97E1D-F104-4D8C-B0F6-743CDDE8AA03Q38438814-84DE1C4E-695B-49CC-96D9-88B93EB3BEEBQ38452047-F6EB3799-736F-42AF-9EE5-C9CC3D90B368Q38516622-14CB825C-2B40-47BF-AA82-DF4EC923C5A0
P2860
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@ast
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@en
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@nl
type
label
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@ast
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@en
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@nl
prefLabel
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@ast
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@en
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
EuroFlow standardization of fl ...... nd immunophenotyping protocols
@en
P2093
A Mendonça
E Mejstrikova
J Flores-Montero
J G te Marvelde
J J M van Dongen
L Lhermitte
P2860
P2888
P304
P3181
P356
10.1038/LEU.2012.122
P407
P5008
P577
2012-09-01T00:00:00Z
P5875
P6179
1045954846